A brain-focused biotech raises $225M to develop drugs for schizophrenia, Parkinson's
BioPharma
Source: biopharmadive.com
Light Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Light Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Light Therapeutics Today - Breaking & Trending Today
MAPLIGHT THERAPEUTICS APPOINTS TIM GARNETT, M.D. TO BOARD OF DIRECTORS
/PRNewswire/ -- MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted, novel therapeutics to improve the lives of...
Source: prnewswire.com
MAPLIGHT THERAPEUTICS APPOINTS KRIS HANSON AS GENERAL COUNSEL
/PRNewswire/ -- MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted, novel therapeutics to improve the lives of...
Source: prnewswire.com
MAPLIGHT THERAPEUTICS APPOINTS CHARMAINE LYKINS AS CHIEF COMMERCIAL OFFICER
/PRNewswire/ -- MapLight Therapeutics, a clinical-stage biopharmaceutical company developing targeted, highly effective therapeutics to improve the lives of...
Source: prnewswire.com
MAPLIGHT THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1 CLINICAL TRIAL FOR NOVEL THERAPY TO TREAT PATIENTS WITH SCHIZOPHRENIA OR DYSKINESIAS
/PRNewswire/ -- MapLight Therapeutics announced it has initiated a Phase 1 clinical trial evaluating ML-007, a novel therapeutic developed to target circuits...
Source: prnewswire.com